Drug Device Combination

SUNRISE, Fla., May 11, 2026 Transpire Bio Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted...

BURLINGTON, Massachusetts, USA, April 28, 2026 SQ Innovation has announced that its drug-device combination therapy Lasix® ONYU has achieved...

WOBURN, Mass., Feb. 9, 2026 — Biofrontera Inc. announced positive top-line results from its multicenter Phase 3 clinical trial...